Iopasentis

Iopamidol, the active ingredient in Iopasentis, is a iodinated contrast media presented as a sterile injectable solution for intraarterial and intravenous use. It provides radiopaque contrast to enhance visualization of vascular structures and organs during imaging procedures.

GNH USA supplies Iopasentis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iopasentis, an iodinated contrast agent used in radiographic imaging, is indicated for: - Angiography: improves delineation of blood vessels and vascular pathology. - Computed tomography (CT) imaging: enhances tissue contrast for detailed cross‑sectional images. - Intravenous urography: clarifies the urinary tract anatomy and function.

Adverse reactions may occur following administration of Iopasentis. Most are mild and transient, but serious events are possible.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Nausea or vomiting. - Mild headache. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Thyroid dysfunction due to iodine load. - Cardiovascular collapse or hypotension. - Pulmonary edema. - Seizures.

Before using Iopasentis, clinicians should consider several safety measures. - Assess renal function: evaluate serum creatinine and eGFR prior to administration. - Screen for iodine allergy: obtain a detailed history of hypersensitivity reactions. - Monitor thyroid status: avoid in patients with uncontrolled hyperthyroidism. - Use the lowest effective volume: limit iodine exposure to reduce toxicity risk. - Store at ambient temperature: keep below 25 °C, in the original container, protected from light and moisture.

Iopasentis may interact with other agents that affect renal function or iodine handling.

Major Interactions (Avoid): - Concurrent iodinated contrast agents: cumulative iodine load increases toxicity. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): heightened risk of renal injury. - Thyroid hormone therapy in hyperthyroid patients: may precipitate thyroid storm.

Moderate Interactions (Monitor Closely): - Diuretics: may alter renal clearance of the contrast. - Metformin: risk of lactic acidosis if renal function declines. - Beta‑blockers: can mask early signs of anaphylaxis.